nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Topotecan—ovarian cancer	0.168	0.354	CbGbCtD
Tinidazole—CYP3A4—Vinorelbine—ovarian cancer	0.118	0.249	CbGbCtD
Tinidazole—CYP3A4—Paclitaxel—ovarian cancer	0.0831	0.175	CbGbCtD
Tinidazole—CYP3A4—Docetaxel—ovarian cancer	0.0601	0.127	CbGbCtD
Tinidazole—CYP3A4—Doxorubicin—ovarian cancer	0.0448	0.0945	CbGbCtD
Tinidazole—Vomiting—Chlorambucil—ovarian cancer	0.000975	0.00185	CcSEcCtD
Tinidazole—Pruritus—Topotecan—ovarian cancer	0.000965	0.00184	CcSEcCtD
Tinidazole—Malnutrition—Paclitaxel—ovarian cancer	0.000962	0.00183	CcSEcCtD
Tinidazole—Feeling abnormal—Vinorelbine—ovarian cancer	0.000962	0.00183	CcSEcCtD
Tinidazole—Asthenia—Melphalan—ovarian cancer	0.000959	0.00182	CcSEcCtD
Tinidazole—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000954	0.00182	CcSEcCtD
Tinidazole—Flatulence—Paclitaxel—ovarian cancer	0.000948	0.0018	CcSEcCtD
Tinidazole—Pruritus—Melphalan—ovarian cancer	0.000945	0.0018	CcSEcCtD
Tinidazole—Dysgeusia—Paclitaxel—ovarian cancer	0.000942	0.00179	CcSEcCtD
Tinidazole—Diarrhoea—Topotecan—ovarian cancer	0.000934	0.00178	CcSEcCtD
Tinidazole—Hypoaesthesia—Docetaxel—ovarian cancer	0.000932	0.00177	CcSEcCtD
Tinidazole—Pharyngitis—Docetaxel—ovarian cancer	0.00093	0.00177	CcSEcCtD
Tinidazole—Urticaria—Vinorelbine—ovarian cancer	0.000927	0.00176	CcSEcCtD
Tinidazole—Urinary tract disorder—Docetaxel—ovarian cancer	0.000925	0.00176	CcSEcCtD
Tinidazole—Muscle spasms—Paclitaxel—ovarian cancer	0.000925	0.00176	CcSEcCtD
Tinidazole—Abdominal pain—Vinorelbine—ovarian cancer	0.000923	0.00175	CcSEcCtD
Tinidazole—Body temperature increased—Vinorelbine—ovarian cancer	0.000923	0.00175	CcSEcCtD
Tinidazole—Urethral disorder—Docetaxel—ovarian cancer	0.000918	0.00175	CcSEcCtD
Tinidazole—Diarrhoea—Melphalan—ovarian cancer	0.000914	0.00174	CcSEcCtD
Tinidazole—Nausea—Chlorambucil—ovarian cancer	0.00091	0.00173	CcSEcCtD
Tinidazole—Dizziness—Topotecan—ovarian cancer	0.000902	0.00172	CcSEcCtD
Tinidazole—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000893	0.0017	CcSEcCtD
Tinidazole—Erythema multiforme—Docetaxel—ovarian cancer	0.000886	0.00168	CcSEcCtD
Tinidazole—Angioedema—Paclitaxel—ovarian cancer	0.000879	0.00167	CcSEcCtD
Tinidazole—Flushing—Docetaxel—ovarian cancer	0.000869	0.00165	CcSEcCtD
Tinidazole—Vomiting—Topotecan—ovarian cancer	0.000868	0.00165	CcSEcCtD
Tinidazole—Malaise—Paclitaxel—ovarian cancer	0.000868	0.00165	CcSEcCtD
Tinidazole—Vertigo—Paclitaxel—ovarian cancer	0.000864	0.00164	CcSEcCtD
Tinidazole—Leukopenia—Paclitaxel—ovarian cancer	0.000861	0.00164	CcSEcCtD
Tinidazole—Rash—Topotecan—ovarian cancer	0.00086	0.00164	CcSEcCtD
Tinidazole—Hypersensitivity—Vinorelbine—ovarian cancer	0.00086	0.00164	CcSEcCtD
Tinidazole—Dermatitis—Topotecan—ovarian cancer	0.00086	0.00163	CcSEcCtD
Tinidazole—Ataxia—Epirubicin—ovarian cancer	0.000859	0.00163	CcSEcCtD
Tinidazole—Headache—Topotecan—ovarian cancer	0.000855	0.00163	CcSEcCtD
Tinidazole—Palpitations—Paclitaxel—ovarian cancer	0.00085	0.00162	CcSEcCtD
Tinidazole—Angiopathy—Docetaxel—ovarian cancer	0.00085	0.00162	CcSEcCtD
Tinidazole—Vomiting—Melphalan—ovarian cancer	0.000849	0.00162	CcSEcCtD
Tinidazole—Immune system disorder—Docetaxel—ovarian cancer	0.000846	0.00161	CcSEcCtD
Tinidazole—Rash—Melphalan—ovarian cancer	0.000842	0.0016	CcSEcCtD
Tinidazole—Dermatitis—Melphalan—ovarian cancer	0.000842	0.0016	CcSEcCtD
Tinidazole—Asthenia—Vinorelbine—ovarian cancer	0.000837	0.00159	CcSEcCtD
Tinidazole—Convulsion—Paclitaxel—ovarian cancer	0.000834	0.00159	CcSEcCtD
Tinidazole—Pruritus—Vinorelbine—ovarian cancer	0.000826	0.00157	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000822	0.00156	CcSEcCtD
Tinidazole—Myalgia—Paclitaxel—ovarian cancer	0.000819	0.00156	CcSEcCtD
Tinidazole—Arthralgia—Paclitaxel—ovarian cancer	0.000819	0.00156	CcSEcCtD
Tinidazole—Malnutrition—Docetaxel—ovarian cancer	0.000815	0.00155	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000813	0.00155	CcSEcCtD
Tinidazole—Nausea—Topotecan—ovarian cancer	0.000811	0.00154	CcSEcCtD
Tinidazole—Discomfort—Paclitaxel—ovarian cancer	0.000809	0.00154	CcSEcCtD
Tinidazole—Diarrhoea—Vinorelbine—ovarian cancer	0.000799	0.00152	CcSEcCtD
Tinidazole—Dysgeusia—Docetaxel—ovarian cancer	0.000798	0.00152	CcSEcCtD
Tinidazole—Ataxia—Doxorubicin—ovarian cancer	0.000795	0.00151	CcSEcCtD
Tinidazole—Nausea—Melphalan—ovarian cancer	0.000794	0.00151	CcSEcCtD
Tinidazole—Confusional state—Paclitaxel—ovarian cancer	0.000792	0.00151	CcSEcCtD
Tinidazole—Muscle spasms—Docetaxel—ovarian cancer	0.000784	0.00149	CcSEcCtD
Tinidazole—Dizziness—Vinorelbine—ovarian cancer	0.000772	0.00147	CcSEcCtD
Tinidazole—Nervous system disorder—Paclitaxel—ovarian cancer	0.00077	0.00146	CcSEcCtD
Tinidazole—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000769	0.00146	CcSEcCtD
Tinidazole—Skin disorder—Paclitaxel—ovarian cancer	0.000763	0.00145	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000761	0.00145	CcSEcCtD
Tinidazole—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000759	0.00144	CcSEcCtD
Tinidazole—Anorexia—Paclitaxel—ovarian cancer	0.000748	0.00142	CcSEcCtD
Tinidazole—Vomiting—Vinorelbine—ovarian cancer	0.000742	0.00141	CcSEcCtD
Tinidazole—Dysuria—Epirubicin—ovarian cancer	0.000738	0.0014	CcSEcCtD
Tinidazole—Neutropenia—Epirubicin—ovarian cancer	0.000738	0.0014	CcSEcCtD
Tinidazole—Rash—Vinorelbine—ovarian cancer	0.000736	0.0014	CcSEcCtD
Tinidazole—Dermatitis—Vinorelbine—ovarian cancer	0.000735	0.0014	CcSEcCtD
Tinidazole—Headache—Vinorelbine—ovarian cancer	0.000731	0.00139	CcSEcCtD
Tinidazole—Leukopenia—Docetaxel—ovarian cancer	0.00073	0.00139	CcSEcCtD
Tinidazole—Palpitations—Docetaxel—ovarian cancer	0.000721	0.00137	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000715	0.00136	CcSEcCtD
Tinidazole—Insomnia—Paclitaxel—ovarian cancer	0.00071	0.00135	CcSEcCtD
Tinidazole—Convulsion—Docetaxel—ovarian cancer	0.000706	0.00134	CcSEcCtD
Tinidazole—Paraesthesia—Paclitaxel—ovarian cancer	0.000705	0.00134	CcSEcCtD
Tinidazole—Drowsiness—Epirubicin—ovarian cancer	0.000704	0.00134	CcSEcCtD
Tinidazole—Dyspnoea—Paclitaxel—ovarian cancer	0.0007	0.00133	CcSEcCtD
Tinidazole—Somnolence—Paclitaxel—ovarian cancer	0.000698	0.00133	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000698	0.00133	CcSEcCtD
Tinidazole—Myalgia—Docetaxel—ovarian cancer	0.000694	0.00132	CcSEcCtD
Tinidazole—Arthralgia—Docetaxel—ovarian cancer	0.000694	0.00132	CcSEcCtD
Tinidazole—Nausea—Vinorelbine—ovarian cancer	0.000693	0.00132	CcSEcCtD
Tinidazole—Dyspepsia—Paclitaxel—ovarian cancer	0.000691	0.00131	CcSEcCtD
Tinidazole—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00069	0.00131	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000689	0.00131	CcSEcCtD
Tinidazole—Stomatitis—Epirubicin—ovarian cancer	0.000686	0.0013	CcSEcCtD
Tinidazole—Urinary tract infection—Epirubicin—ovarian cancer	0.000684	0.0013	CcSEcCtD
Tinidazole—Neutropenia—Doxorubicin—ovarian cancer	0.000683	0.0013	CcSEcCtD
Tinidazole—Dysuria—Doxorubicin—ovarian cancer	0.000683	0.0013	CcSEcCtD
Tinidazole—Decreased appetite—Paclitaxel—ovarian cancer	0.000683	0.0013	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000678	0.00129	CcSEcCtD
Tinidazole—Fatigue—Paclitaxel—ovarian cancer	0.000677	0.00129	CcSEcCtD
Tinidazole—Sweating—Epirubicin—ovarian cancer	0.000675	0.00128	CcSEcCtD
Tinidazole—Constipation—Paclitaxel—ovarian cancer	0.000671	0.00128	CcSEcCtD
Tinidazole—Confusional state—Docetaxel—ovarian cancer	0.000671	0.00128	CcSEcCtD
Tinidazole—Nervous system disorder—Docetaxel—ovarian cancer	0.000653	0.00124	CcSEcCtD
Tinidazole—Thrombocytopenia—Docetaxel—ovarian cancer	0.000652	0.00124	CcSEcCtD
Tinidazole—Drowsiness—Doxorubicin—ovarian cancer	0.000651	0.00124	CcSEcCtD
Tinidazole—Feeling abnormal—Paclitaxel—ovarian cancer	0.000647	0.00123	CcSEcCtD
Tinidazole—Skin disorder—Docetaxel—ovarian cancer	0.000646	0.00123	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000646	0.00123	CcSEcCtD
Tinidazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000642	0.00122	CcSEcCtD
Tinidazole—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000638	0.00121	CcSEcCtD
Tinidazole—Stomatitis—Doxorubicin—ovarian cancer	0.000635	0.00121	CcSEcCtD
Tinidazole—Anorexia—Docetaxel—ovarian cancer	0.000634	0.00121	CcSEcCtD
Tinidazole—Urinary tract infection—Doxorubicin—ovarian cancer	0.000633	0.0012	CcSEcCtD
Tinidazole—Hypoaesthesia—Epirubicin—ovarian cancer	0.000629	0.0012	CcSEcCtD
Tinidazole—Pharyngitis—Epirubicin—ovarian cancer	0.000627	0.00119	CcSEcCtD
Tinidazole—Sweating—Doxorubicin—ovarian cancer	0.000624	0.00119	CcSEcCtD
Tinidazole—Urinary tract disorder—Epirubicin—ovarian cancer	0.000624	0.00119	CcSEcCtD
Tinidazole—Urticaria—Paclitaxel—ovarian cancer	0.000624	0.00119	CcSEcCtD
Tinidazole—Abdominal pain—Paclitaxel—ovarian cancer	0.000621	0.00118	CcSEcCtD
Tinidazole—Body temperature increased—Paclitaxel—ovarian cancer	0.000621	0.00118	CcSEcCtD
Tinidazole—Urethral disorder—Epirubicin—ovarian cancer	0.000619	0.00118	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000606	0.00115	CcSEcCtD
Tinidazole—Insomnia—Docetaxel—ovarian cancer	0.000602	0.00114	CcSEcCtD
Tinidazole—Paraesthesia—Docetaxel—ovarian cancer	0.000598	0.00114	CcSEcCtD
Tinidazole—Erythema multiforme—Epirubicin—ovarian cancer	0.000597	0.00114	CcSEcCtD
Tinidazole—Dyspnoea—Docetaxel—ovarian cancer	0.000593	0.00113	CcSEcCtD
Tinidazole—Somnolence—Docetaxel—ovarian cancer	0.000592	0.00113	CcSEcCtD
Tinidazole—Flushing—Epirubicin—ovarian cancer	0.000586	0.00112	CcSEcCtD
Tinidazole—Dyspepsia—Docetaxel—ovarian cancer	0.000586	0.00111	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000582	0.00111	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—ovarian cancer	0.00058	0.0011	CcSEcCtD
Tinidazole—Decreased appetite—Docetaxel—ovarian cancer	0.000578	0.0011	CcSEcCtD
Tinidazole—Hypersensitivity—Paclitaxel—ovarian cancer	0.000578	0.0011	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000577	0.0011	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000575	0.00109	CcSEcCtD
Tinidazole—Fatigue—Docetaxel—ovarian cancer	0.000574	0.00109	CcSEcCtD
Tinidazole—Angiopathy—Epirubicin—ovarian cancer	0.000573	0.00109	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—ovarian cancer	0.000573	0.00109	CcSEcCtD
Tinidazole—Immune system disorder—Epirubicin—ovarian cancer	0.000571	0.00109	CcSEcCtD
Tinidazole—Constipation—Docetaxel—ovarian cancer	0.000569	0.00108	CcSEcCtD
Tinidazole—Asthenia—Paclitaxel—ovarian cancer	0.000563	0.00107	CcSEcCtD
Tinidazole—Pruritus—Paclitaxel—ovarian cancer	0.000555	0.00106	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—ovarian cancer	0.000553	0.00105	CcSEcCtD
Tinidazole—Malnutrition—Epirubicin—ovarian cancer	0.00055	0.00105	CcSEcCtD
Tinidazole—Feeling abnormal—Docetaxel—ovarian cancer	0.000548	0.00104	CcSEcCtD
Tinidazole—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000544	0.00103	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—ovarian cancer	0.000543	0.00103	CcSEcCtD
Tinidazole—Flatulence—Epirubicin—ovarian cancer	0.000542	0.00103	CcSEcCtD
Tinidazole—Dysgeusia—Epirubicin—ovarian cancer	0.000539	0.00102	CcSEcCtD
Tinidazole—Diarrhoea—Paclitaxel—ovarian cancer	0.000537	0.00102	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—ovarian cancer	0.00053	0.00101	CcSEcCtD
Tinidazole—Muscle spasms—Epirubicin—ovarian cancer	0.000529	0.00101	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—ovarian cancer	0.000528	0.001	CcSEcCtD
Tinidazole—Abdominal pain—Docetaxel—ovarian cancer	0.000526	0.001	CcSEcCtD
Tinidazole—Body temperature increased—Docetaxel—ovarian cancer	0.000526	0.001	CcSEcCtD
Tinidazole—Dizziness—Paclitaxel—ovarian cancer	0.000519	0.000987	CcSEcCtD
Tinidazole—Ill-defined disorder—Epirubicin—ovarian cancer	0.00051	0.00097	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—ovarian cancer	0.000509	0.000968	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—ovarian cancer	0.000501	0.000954	CcSEcCtD
Tinidazole—Vomiting—Paclitaxel—ovarian cancer	0.000499	0.000949	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—ovarian cancer	0.000498	0.000948	CcSEcCtD
Tinidazole—Malaise—Epirubicin—ovarian cancer	0.000496	0.000943	CcSEcCtD
Tinidazole—Rash—Paclitaxel—ovarian cancer	0.000495	0.000941	CcSEcCtD
Tinidazole—Dermatitis—Paclitaxel—ovarian cancer	0.000495	0.000941	CcSEcCtD
Tinidazole—Vertigo—Epirubicin—ovarian cancer	0.000494	0.00094	CcSEcCtD
Tinidazole—Leukopenia—Epirubicin—ovarian cancer	0.000492	0.000936	CcSEcCtD
Tinidazole—Headache—Paclitaxel—ovarian cancer	0.000492	0.000935	CcSEcCtD
Tinidazole—Hypersensitivity—Docetaxel—ovarian cancer	0.00049	0.000932	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—ovarian cancer	0.000489	0.00093	CcSEcCtD
Tinidazole—Palpitations—Epirubicin—ovarian cancer	0.000486	0.000924	CcSEcCtD
Tinidazole—Asthenia—Docetaxel—ovarian cancer	0.000477	0.000908	CcSEcCtD
Tinidazole—Convulsion—Epirubicin—ovarian cancer	0.000477	0.000906	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000472	0.000898	CcSEcCtD
Tinidazole—Pruritus—Docetaxel—ovarian cancer	0.000471	0.000895	CcSEcCtD
Tinidazole—Arthralgia—Epirubicin—ovarian cancer	0.000468	0.00089	CcSEcCtD
Tinidazole—Myalgia—Epirubicin—ovarian cancer	0.000468	0.00089	CcSEcCtD
Tinidazole—Nausea—Paclitaxel—ovarian cancer	0.000466	0.000887	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000465	0.000884	CcSEcCtD
Tinidazole—Discomfort—Epirubicin—ovarian cancer	0.000463	0.00088	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—ovarian cancer	0.000459	0.000873	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—ovarian cancer	0.000457	0.000869	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—ovarian cancer	0.000456	0.000866	CcSEcCtD
Tinidazole—Diarrhoea—Docetaxel—ovarian cancer	0.000455	0.000866	CcSEcCtD
Tinidazole—Confusional state—Epirubicin—ovarian cancer	0.000453	0.000861	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—ovarian cancer	0.00045	0.000855	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—ovarian cancer	0.000441	0.000838	CcSEcCtD
Tinidazole—Nervous system disorder—Epirubicin—ovarian cancer	0.00044	0.000837	CcSEcCtD
Tinidazole—Dizziness—Docetaxel—ovarian cancer	0.00044	0.000837	CcSEcCtD
Tinidazole—Thrombocytopenia—Epirubicin—ovarian cancer	0.000439	0.000836	CcSEcCtD
Tinidazole—Skin disorder—Epirubicin—ovarian cancer	0.000436	0.000829	CcSEcCtD
Tinidazole—Hyperhidrosis—Epirubicin—ovarian cancer	0.000434	0.000825	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—ovarian cancer	0.000433	0.000824	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—ovarian cancer	0.000433	0.000824	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00043	0.000818	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—ovarian cancer	0.000428	0.000814	CcSEcCtD
Tinidazole—Anorexia—Epirubicin—ovarian cancer	0.000428	0.000814	CcSEcCtD
Tinidazole—Vomiting—Docetaxel—ovarian cancer	0.000423	0.000805	CcSEcCtD
Tinidazole—Rash—Docetaxel—ovarian cancer	0.00042	0.000798	CcSEcCtD
Tinidazole—Dermatitis—Docetaxel—ovarian cancer	0.000419	0.000797	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—ovarian cancer	0.000419	0.000796	CcSEcCtD
Tinidazole—Headache—Docetaxel—ovarian cancer	0.000417	0.000793	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000409	0.000778	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—ovarian cancer	0.000407	0.000775	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000407	0.000773	CcSEcCtD
Tinidazole—Insomnia—Epirubicin—ovarian cancer	0.000406	0.000772	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—ovarian cancer	0.000403	0.000767	CcSEcCtD
Tinidazole—Paraesthesia—Epirubicin—ovarian cancer	0.000403	0.000766	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000402	0.000764	CcSEcCtD
Tinidazole—Dyspnoea—Epirubicin—ovarian cancer	0.0004	0.000761	CcSEcCtD
Tinidazole—Somnolence—Epirubicin—ovarian cancer	0.000399	0.000759	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—ovarian cancer	0.000396	0.000753	CcSEcCtD
Tinidazole—Nausea—Docetaxel—ovarian cancer	0.000395	0.000752	CcSEcCtD
Tinidazole—Dyspepsia—Epirubicin—ovarian cancer	0.000395	0.000751	CcSEcCtD
Tinidazole—Decreased appetite—Epirubicin—ovarian cancer	0.00039	0.000742	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000388	0.000737	CcSEcCtD
Tinidazole—Fatigue—Epirubicin—ovarian cancer	0.000387	0.000736	CcSEcCtD
Tinidazole—Constipation—Epirubicin—ovarian cancer	0.000384	0.00073	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000378	0.00072	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—ovarian cancer	0.000376	0.000714	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—ovarian cancer	0.000373	0.000709	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—ovarian cancer	0.00037	0.000704	CcSEcCtD
Tinidazole—Feeling abnormal—Epirubicin—ovarian cancer	0.00037	0.000703	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—ovarian cancer	0.000369	0.000702	CcSEcCtD
Tinidazole—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000367	0.000698	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—ovarian cancer	0.000366	0.000695	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—ovarian cancer	0.000361	0.000687	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000359	0.000682	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—ovarian cancer	0.000358	0.000681	CcSEcCtD
Tinidazole—Urticaria—Epirubicin—ovarian cancer	0.000357	0.000678	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—ovarian cancer	0.000355	0.000675	CcSEcCtD
Tinidazole—Abdominal pain—Epirubicin—ovarian cancer	0.000355	0.000675	CcSEcCtD
Tinidazole—Body temperature increased—Epirubicin—ovarian cancer	0.000355	0.000675	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—ovarian cancer	0.000342	0.000651	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00034	0.000646	CcSEcCtD
Tinidazole—Hypersensitivity—Epirubicin—ovarian cancer	0.000331	0.000629	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—ovarian cancer	0.00033	0.000627	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—ovarian cancer	0.000328	0.000624	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—ovarian cancer	0.000328	0.000624	CcSEcCtD
Tinidazole—Asthenia—Epirubicin—ovarian cancer	0.000322	0.000612	CcSEcCtD
Tinidazole—Pruritus—Epirubicin—ovarian cancer	0.000318	0.000604	CcSEcCtD
Tinidazole—Diarrhoea—Epirubicin—ovarian cancer	0.000307	0.000584	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—ovarian cancer	0.000306	0.000582	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—ovarian cancer	0.000298	0.000567	CcSEcCtD
Tinidazole—Dizziness—Epirubicin—ovarian cancer	0.000297	0.000564	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—ovarian cancer	0.000294	0.000559	CcSEcCtD
Tinidazole—Vomiting—Epirubicin—ovarian cancer	0.000285	0.000543	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—ovarian cancer	0.000284	0.00054	CcSEcCtD
Tinidazole—Rash—Epirubicin—ovarian cancer	0.000283	0.000538	CcSEcCtD
Tinidazole—Dermatitis—Epirubicin—ovarian cancer	0.000283	0.000538	CcSEcCtD
Tinidazole—Headache—Epirubicin—ovarian cancer	0.000281	0.000535	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—ovarian cancer	0.000275	0.000522	CcSEcCtD
Tinidazole—Nausea—Epirubicin—ovarian cancer	0.000267	0.000507	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—ovarian cancer	0.000264	0.000502	CcSEcCtD
Tinidazole—Rash—Doxorubicin—ovarian cancer	0.000262	0.000498	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—ovarian cancer	0.000262	0.000498	CcSEcCtD
Tinidazole—Headache—Doxorubicin—ovarian cancer	0.00026	0.000495	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—ovarian cancer	0.000247	0.000469	CcSEcCtD
